ClinicalTrials.gov
public full text
Public Domain
Intrapleural Urokinase for Retained Hemothorax
Intrapleural thrombolytic treatment with urokinase for retained hemothorax is effective and safe. However, previous study was limited in prospective observation study without control group.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dexmedetomidine Improved Oxygenation and Reduced Shunt in One-Lung Ventilation at High-Risk Pediatric Thoracic Surgery#1162005
- Selective Lung Recruitment in Moderate to Severe ARDS : a Pilot Study#1101849
- Treatment for Blood Clots in the Veins of the Legs#1139107
- Clinical Trial of Systolic Heart Failure Treatment of IvabRadine Hemisulfate Sustained-release Tablets （FIRST）#834140
- Soluble urokinase plasminogen activator receptor (suPAR) plasma concentration is reduced using minimized extracorporeal circulation : results of a secondary analysis of a prospective observational study#449078
Record · ID 877800
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive